Stay updated on Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial page.

Latest updates to the Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No changes to study content or criteria are observed.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedExpanded the study locations to include additional sites across the US and Canada (e.g., Alabama, Alaska, Ontario, Quebec). The revision was updated to v3.3.3.SummaryDifference2%

- Check37 days agoChange DetectedDifference0.1%

- Check59 days agoChange DetectedPublications are now described as automatically filled from PubMed with updated wording, the old PubMed sentence was removed, and a site revision tag 'Revision: v3.3.2' was added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check66 days agoChange DetectedRemoved the government funding status notice banner from the page; the study details and other core content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange DetectedNo significant content changes were detected between the two screenshots. The page still presents the same study details, eligibility criteria, and locations as before.SummaryDifference0.2%

Stay in the know with updates to Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial page.